Pramlintide for diabetes mellitus - Wikidata - wikimedia - TriplyDB

Pramlintide for diabetes mellitus

Pramlintide for diabetes mellitus

http://www.wikidata.org/entity/Q24186857

about

Pramlintide for diabetes mellitus

http://www.wikidata.org/entity/Q24186857

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pramlintide for diabetes mellitus

@ast

Pramlintide for diabetes mellitus

@en

Pramlintide for diabetes mellitus

@en-gb

Pramlintide for diabetes mellitus

@nl

type

label

Pramlintide for diabetes mellitus

@ast

Pramlintide for diabetes mellitus

@en

Pramlintide for diabetes mellitus

@en-gb

Pramlintide for diabetes mellitus

@nl

prefLabel

Pramlintide for diabetes mellitus

@ast

Pramlintide for diabetes mellitus

@en

Pramlintide for diabetes mellitus

@en-gb

Pramlintide for diabetes mellitus

@nl

P1433

Q24186857-85116B49-B9DD-482A-BCF8-5BE83CFF5F43

P1476

Q24186857-DB22DD5B-30D1-4982-A93C-A18590CFEBEC

P2093

Q24186857-23A65A0A-E870-42F0-A30C-8CC0E9A998A0

Q24186857-3FD00612-75C6-486F-9B1E-1882AEE2C33B

Q24186857-833C5C6A-62B5-4286-9C89-A9CAA4A79B8C

Q24186857-C48278E0-F011-4160-9BFC-828B5B8CC2F0

P2860

Q24186857-04005304-3EA8-4EE9-92B5-8901A6622C99

Q24186857-121644D4-7C67-471E-8128-28E13B82AEE8

Q24186857-13ADF50E-7EFC-4069-B5E2-84848C27CD9D

Q24186857-1BC220CD-2E30-4997-AA59-FCE5E7DEF280

Q24186857-1C060018-E60A-45C2-B31F-7B78026427F6

Q24186857-208BF883-C38C-4793-B5D4-7031648F026E

Q24186857-2581A302-E53E-4043-A799-805A19E212DF

Q24186857-2AE6C7B9-AF2F-4FAC-A5A7-1869AF2AB1BE

Q24186857-349C3E21-0270-4F48-B989-870557B196F4

Q24186857-382B700D-499B-4B6E-BDD9-8DE16B635185

P31

Q24186857-A24FECB5-04C1-4C50-8F79-06B67F928C9F

P356

Q24186857-1DF7720E-CA43-45AD-9A9E-B55A89C311D3

P577

Q24186857-678F6C16-45DB-406F-B91C-E88941E49D05

P356

14651858.CD008383.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Pramlintide for diabetes mellitus

@en

P2093

Christopher William Loughlan

http://www.w3.org/2001/XMLSchema#string

Cristian Baicus

http://www.w3.org/2001/XMLSchema#string

Diana Hortensia Barbonta

http://www.w3.org/2001/XMLSchema#string

JE Claire Dickerson

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Statistics notes: blinding in clinical trials and other studies.

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

P31

scholarly article

P356

10.1002/14651858.CD008383.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime